Copyright
©The Author(s) 2023.
World J Diabetes. Jul 15, 2023; 14(7): 1057-1076
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1057
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1057
Figure 1 HPLC-VWD mass spectrometry.
A: Key components of Shuxin decoction (SXT) identified by HPLC-VWD mass spectrometry; B: HPLC-VWD mass spectrometry of SXT. 1-6 represent verisoflavone glucoside, ferulic acid, cinnamaldehyde, ginsenosides Rb1, 6-gingerol, and tanshinone ⅡA, respectively. SXT: Shuxin decoction.
- Citation: Yang L, Jian Y, Zhang ZY, Qi BW, Li YB, Long P, Yang Y, Wang X, Huang S, Huang J, Zhou LF, Ma J, Jiang CQ, Hu YH, Xiao WJ. Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes. World J Diabetes 2023; 14(7): 1057-1076
- URL: https://www.wjgnet.com/1948-9358/full/v14/i7/1057.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i7.1057